323 results on '"Schulz, Lucas"'
Search Results
2. Finding value in novel antibiotics: How can infectious diseases adopt incremental cost-effectiveness to improve new antibiotic utilization?
3. Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients
4. A geospatial approach to identify patterns of antibiotic susceptibility at a neighborhood level in Wisconsin, United States
5. 530: EVALUATION OF GRAM STAIN-GUIDED ANTIBIOTIC THERAPY FOR MRSA PNEUMONIA IN ICU PATIENTS
6. COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department
7. ANTIMICROBIAL STEWARDSHIP SYSTEM EXPANSION
8. Evaluation of Gram Stain-Guided Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus Pneumonia in Intensive Care Unit Patients.
9. Remdesivir Use in Pediatric Patients for SARS-CoV-2 Treatment: Single Academic Center Study
10. Remdesivir Use in Pediatric Patients for SARS-CoV-2 Treatment: Single Academic Center Study
11. CMV antiviral stewardship: navigating obstacles to facilitate target attainment
12. Association of Penicillin or Cephalosporin Allergy Documentation and Antibiotic Use in Hospitalized Patients with Pneumonia
13. Multiple Lactobacillus Infections Caused by Probiotics at Pediatric and Adult Academic Medical Centers.
14. β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value
15. Significance of curvature for balancing polymer melt channels in injection molding manifold systems and extrusion dies.
16. Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience
17. Antimicrobial stewardship during a time of rapid antimicrobial development: Potential impact on industry for future investment
18. In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistance
19. Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia
20. 530: EVALUATION OF GRAM STAIN-GUIDED ANTIBIOTIC THERAPY FOR MRSA PNEUMONIA IN ICU PATIENTS
21. 2269. Inpatient Antibiotic Prescribing for Symptomatic COVID-19 Patients in a Large US Sample, 2020-2022
22. Understanding clinical implementation coordinators’ experiences in deploying evidence-based interventions
23. Top 10 Myths Regarding the Diagnosis and Treatment of Cellulitis
24. Evaluating distributive mixing potential by mean distance of streamlines and a passive scalar.
25. Examining the effects of organizational influencers on the implementation of clinical innovations: A qualitative analysis
26. Top Ten Myths Regarding the Diagnosis and Treatment of Urinary Tract Infections
27. MALDI-TOF Utility in a Region With Low Antibacterial Resistance Rates
28. Neutropenic Fever–Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 Pandemic
29. Isavuconazole: Has It Saved Us? A Pharmacotherapy Review and Update on Clinical Experience
30. Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia
31. 875. Guess Who’s Back: The Return of Seasonal Respiratory Viruses in the State of Wisconsin and Associated Changes in Antibiotic Prescribing for Respiratory Complaints
32. 927. Successful Implementation of an Inpatient Fluoroquinolone (FQ) Pre-Authorization (PA) Program at a Tertiary Care Academic Center and Associated Changes in Antibiotic Use, Antibiogram Susceptibility, and Provider Behavioral Changes
33. Nirmatrelvir‐ritonavir treatment of COVID ‐19 in a high‐risk patient population: A retrospective observational study
34. CMV antiviral stewardship: navigating obstacles to facilitate target attainment
35. Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard
36. Use of Electronic Health Records and Clinical Decision Support Systems for Antimicrobial Stewardship
37. Understanding inpatient antimicrobial stewardship metrics
38. Multiple‐Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections
39. Impact of Low Procalcitonin Results on Antibiotic Administration in Hospitalized Patients at a Tertiary Care Center
40. A Perfect Storm: COVID-19 and Antimicrobial Resistance
41. Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations
42. Telestewardship programs support clinical care and improve fiscal outcomes across the continuum through partnership between hospitals and health systems: A systematic review
43. The Use of Best Practice Alerts with the Development of an Antimicrobial Stewardship Navigator to Promote Antibiotic De-escalation in the Electronic Medical Record
44. The "Epic" Challenge of Optimizing Antimicrobial Stewardship: The Role of Electronic Medical Records and Technology
45. Top 1% of Inpatients Administered Antimicrobial Agents Comprising 50% of Expenditures: A Descriptive Study and Opportunities for Stewardship Intervention
46. Effectiveness and Safety of Tigecycline Compared with Other Broad‐Spectrum Antimicrobials in Abdominal Solid Organ Transplant Recipients with Polymicrobial Intraabdominal Infections
47. Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations.
48. Use of Electronic Health Record Clinical Decision Support Tools in Antimicrobial Stewardship Activities
49. Automated optimization of a block-head-mixer with an innovative algorithm
50. The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.